Flat colorectal neoplasms and the impact of the revised Vienna Classification on their reporting: a case-control study in UK and Japanese patients

The Importance of Histology and Pathology in Mass Spectrometry Imaging

Mass spectrometry imaging (MSI) has become a valuable tool in cancer research. Even more, due to its capability to directly link molecular changes with histology, it holds the prospect to revolutionize tissue-based diagnostics. In order to learn to walk before running, however, information obtained through classical histology should not be neglected but rather used to its full capacity and integrated with mass spectrometry data to lead to a superior molecular histology synthesis. In order to achieve this, pathomorphological analyses have to be integrated into MSI analyses right from the beginning to avoid errors and pitfalls of MSI application possibly leading to incorrect or imprecise study outcomes. Such errors can be caused by different sample or tissue inherent factors or through factors in sample preparation. Future studies should, therefore, aim for a comprehensive incorporation of histology and pathology characteristics to ensure the generation of high-quality data in MSI to exploit its full capacity in tissue-based basic and translational research.

CT colonography for the detection of nonpolypoid adenomas: sensitivity assessed with restricted national CT colonography trial criteria

OBJECTIVE

The purpose of this study was to determine the prevalence of nonpolypoid adenomas and the sensitivity of CT colonography (CTC) in their detection by use of the restricted criteria of height-to-width ratio<50% and height elevation≤3 mm.

MATERIALS AND METHODS

In the National CT Colonography Trial (American College of Radiology Imaging Network protocol 6664), a cohort of 2531 participants without symptoms underwent CTC and screening colonoscopy. The CTC examinations were interpreted with both 2D and 3D techniques. Nonpolypoid adenomatous polyps identified with CTC or colonoscopy were retrospectively reviewed to determine which polyps met the restricted criteria. The prevalence of nonpolypoid adenomas and the prospective sensitivity of CTC were determined. Descriptive statistics were used to report the prevalence, size, and histologic features. The sensitivities (with 95% CIs) for nonpolypoid and polypoid lesions were compared by two-sided Z test for independent binomial proportions.

RESULTS

The retrospective review confirmed 21 nonpolypoid adenomas, yielding a prevalence of 0.83% (21 of 2531 participants). Eight (38.1%) were advanced adenomas, many (50% [4/8]) only because of large size (≥10 mm). The overall per polyp sensitivity of CTC (combined 2D and 3D interpretation) for detecting nonpolypoid adenomas≥5 mm (n=21) was 0.76; ≥6 mm (n=16), 0.75; and ≥10 mm (n=5), 0.80. These values were not statistically different from the sensitivity of detecting polypoid adenomas (p>0.37).

CONCLUSION

In this large screening population, nonpolypoid adenomas had a very low prevalence (<1%), and advanced pathologic features were uncommon in polyps<10 mm in diameter. Most nonpolypoid adenomas are technically visible at CTC. The prospective sensitivity is similar to that for polypoid adenomas when the interpretation combines both 2D and 3D review.

Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations

In Europe, colorectal cancer is the most common newly diagnosed cancer and the second most common cause of cancer deaths, accounting for approximately 436,000 incident cases and 212,000 deaths in 2008. The potential of high-quality screening to improve control of the disease has been recognized by the Council of the European Union who issued a recommendation on cancer screening in 2003. Multidisciplinary, evidence-based European Guidelines for quality assurance in colorectal cancer screening and diagnosis have recently been developed by experts in a pan-European project coordinated by the International Agency for Research on Cancer. The full guideline document consists of ten chapters and an extensive evidence base. The content of the chapter dealing with pathology in colorectal cancer screening and diagnosis is presented here in order to promote international discussion and collaboration leading to improvements in colorectal cancer screening and diagnosis by making the principles and standards recommended in the new EU Guidelines known to a wider scientific community.

Flat colon polyps: what should radiologists know?

With the recent publication of international computed tomography (CT) colonography standards, which aim to improve quality of examinations, this review informs radiologists about the significance of flat polyps (adenomas and hyperplastic polyps) in colorectal cancer pathways. We describe flat polyp classification systems and propose how flat polyps should be reported to ensure patient management strategies are based on polyp morphology as well as size. Indeed, consistency when describing flat polyps is of increasing importance given the strengthening links between CT colonography and endoscopy.

Non-polypoid colorectal neoplasms are relatively common worldwide

Flat adenomas are found commonly at colonoscopy throughout the world. Similarly, small, flat submucosally invasive cancers have been described worldwide but are relatively rare, accounting for 5% to 10% of all cancers detected at colonoscopy. Although there appears to be no difference in frequency of non-polypoid colorectal neoplasms between East and West, considerable variation has been reported by individual studies, probably because of lack of consistency when defining a flat lesion. Flat elevated lesions are the most common type of flat lesion and do not appear to have a greatly increased risk of harboring invasive malignancy; however, flat lesions with depression have a significant risk of malignancy and are probably the precursor lesions for most small, flat, or ulcerating cancers.

CT colonography and non-polypoid colorectal neoplasms

Computed tomographic colonography (CTC) has been reported to be as effective as optical colonoscopy in the detection of significant adenomas. However, there are widely conflicting performance data in relation to detection of flat neoplasia. This article describes the potential and limitations of CTC and computer-aided diagnosis in the detection of flat neoplasms.

Flat (nonpolypoid) colorectal lesions identified at CT colonography in a U.S. screening population

RATIONALE AND OBJECTIVES

The aim of this study was to investigate the clinical importance and height definition of flat (nonpolypoid) colorectal lesions detected on screening computed tomographic colonography (CTC).

MATERIALS AND METHODS

Results from prospective screening CTC in 5107 consecutive asymptomatic adults (mean age, 56.9 years) at a single center were analyzed. All detected colorectal lesions > or = 6 mm were prospectively categorized as polypoid or flat (nonpolypoid). The maximal height of all flat lesions was measured to assess the suggested 3-mm threshold definition.

RESULTS

Of 954 polyps measuring > or = 6 mm identified on screening CTC, 125 lesions (13.1%) in 106 adults were prospectively categorized as flat, with a mean size of 12.7 mm (range, 6-80 mm), including 73 lesions 6 to 9 mm, 42 lesions 10 to 29 mm, and 10 lesions > or = 3 cm (carpet lesions). For polyps between 6 and 30 mm in size, flat lesions were less likely than polypoid lesions to be neoplastic (25.0% vs 60.3%, P < .001), histologically advanced (5.4% vs 12.1%, P = .07) or malignant (0% vs 0.5%, P = NS). Two of 10 carpet lesions (20%) were malignant, compared to 50% of polypoid masses > or = 3 cm. Of nine flat lesions seen only on colonoscopy (false-negatives on CTC), two were neoplastic (tubular adenomas), and none was histologically advanced. For all flat lesions between 6 and 30 mm, the maximal height averaged 2.2 mm and was < or =3 mm in 86.1%, including 93.2% of small 6-mm to 9-mm flat lesions.

CONCLUSION

In a US screening population, flat colorectal lesions detected on CTC demonstrated less aggressive histologic features compared to polypoid lesions. Excluding carpet lesions, a maximal height of 3 mm appears to be a reasonable definition.

[Dysplasia in glandular digestive tissues: new concepts, new classifications]

The term of dysplasia is currently used to designate morphological alterations, identifiable at microscopic examination, revealing the existence of an unequivocally neoplastic process, at an early, non-invasive, stage of its natural history. The pathologist bears the full responsibility for the diagnosis of dysplasia, based on a broad spectrum of cytological and architectural abnormalities. It is important to grade the severity of the dysplastic lesions, in order to help guide clinical management and choose the therapeutic strategy. The Vienna classification, proposed in 2000 as a compromise between the Western and Japanese concepts, is now used for classification and grading of digestive epithelial dysplasia. The major advantages of the Vienna classification are the use of uniform terminology worldwide, achievement of good diagnostic reproducibility between pathologists and clear and consensual clinical consequences. Its use is strongly supported by the recent international recommendations.

Clinicopathologic characteristics and malignant potential of colorectal flat neoplasia compared with that of polypoid neoplasia

PURPOSE

Because of their potential for malignancy, flat colorectal neoplasias are a current topic of debate. This study was designed to investigate the clinicopathologic features of flat neoplasia and to compare them with those of polypoid neoplasia, as well as to identify the determinants of malignant transformation of both flat and polypoid colorectal neoplasia.

METHODS

A prospective, cross-sectional study of 3,360 patients diagnosed with adenomas via total colonoscopy and polypectomy was performed at 11 tertiary medical centers between July 2003 and July 2004. In this study, potential risk factors for malignant transformation were analyzed. If multiple adenomas were identified, then only the adenoma with the most advanced degree of histology was recorded for the patient.

RESULTS

Of a total of 3,360 neoplasias identified, we found that the incidence of flat and polypoid neoplasias were 207 (6.2 percent) and 3,153 (93.8 percent), respectively. Patients with flat neoplasias tended to be older (59.6 vs. 57.1, P < 0.01), with the neoplasia located more frequently in the right colon than polypoid neoplasias (49.3 percent vs. 32 percent, P < 0.01). The incidence of high-grade dysplasia or cancer in flat neoplasias was similar to that of polypoid neoplasias (5.4 percent vs. 4.6 percent, P = 0.36). Multivariate analysis revealed that a size of > or =11 mm (odds ratio, 6.8; 95 percent confidence interval, 4.8-9.7) and location in the left colon (odds ratio, 1.6; 95 percent confidence interval, 1.1-2.4) were significant determinants for the malignancy potential of colonic neoplasias.

CONCLUSIONS

The clinicopathologic indices for the propensity of malignant transformation in colorectal neoplasias were a size > or =11 mm and location in the left colon rather than flat gross morphology.